Genome sequence data of multidrug-resistant Enterococcus faecalis HMTZ24 carrying multiple virulence factors,

Talal S Salih1, Zeyad T Al-Rrassam1, Muhammad A Muhammad2

  • 1Department of Medical Physics, College of Science, University of Mosul, Iraq.

Data in Brief
|January 2, 2026
PubMed

Insights

We present the draft genome sequence of Enterococcus faecalis strain HMTZ24, isolated from a UTI patient in Iraq. This genomic data reveals antimicrobial resistance and virulence factors, aiding future research on this common pathogen.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Enterococcus faecalis is a significant cause of urinary tract infections (UTIs) globally.
  • Understanding the genetic makeup of E. faecalis strains is crucial for combating antibiotic resistance and infection spread.

Purpose of the Study:

  • To present the draft genome sequence of Enterococcus faecalis strain HMTZ24.
  • To identify antimicrobial resistance genes and virulence factors within this strain.
  • To provide a genomic resource for studying E. faecalis epidemiology and pathogenesis.

Main Methods:

  • Whole-genome sequencing using Illumina NovaSeq 6000.
  • Bioinformatic analysis including genome assembly, annotation, phylogenomic taxonomy, and MLST.
  • Identification of antimicrobial resistance genes, mobile genetic elements, and virulence factors.

Main Results:

  • The assembled genome is 2.62 Mbp with 2,510 coding sequences.
  • Strain HMTZ24 belongs to Sequence Type 28 (ST28) and is closely related to reference strains.
  • The genome contains multiple antimicrobial resistance genes (e.g., vancomycin, ciprofloxacin) and 14 virulence factors (e.g., ace, ebpA).

Conclusions:

  • The HMTZ24 genome provides valuable insights into the genetic basis of antimicrobial resistance and virulence in E. faecalis.
  • This genomic data supports comparative studies and enhances understanding of regional E. faecalis epidemiology.
  • The availability of this genome sequence facilitates further research into UTI pathogenesis and treatment strategies.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
440
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
59
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
92
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106